Catheter ablation versus antiarrhythmic drug therapy for sustained ventricular tachycardia in patien...
Catheter ablation versus antiarrhythmic drug therapy for sustained ventricular tachycardia in patients with hypertrophic cardiomyopathy
About this item
Full title
Author / Creator
Dong, Yan , Song, Xudong , Bo, Dan , Wang, Hongtao , Yang, Bo , Yadav, Nishant , Chen, Qiushi , Xu, Ruochen , Chen, Hongwu , Ju, Weizhu , Cao, Kejiang , Chen, Minglong and Zhang, Fengxiang
Publisher
England: BioMed Central Ltd
Journal title
Language
English
Formats
Publication information
Publisher
England: BioMed Central Ltd
Subjects
More information
Scope and Contents
Contents
Ventricular tachycardia (VT) is the primary cause of sudden cardiac death in patients with hypertrophic cardiomyopathy (HCM). However, the strategy for VT treatment in HCM patients remains unclear. This study is aimed to compare the effectiveness of catheter ablation versus antiarrhythmic drug (AAD) therapy for sustained VT in patients with HCM.
Alternative Titles
Full title
Catheter ablation versus antiarrhythmic drug therapy for sustained ventricular tachycardia in patients with hypertrophic cardiomyopathy
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_3656eef2af204f87aa0c2d083cbfc0d9
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_3656eef2af204f87aa0c2d083cbfc0d9
Other Identifiers
ISSN
1471-2261
E-ISSN
1471-2261
DOI
10.1186/s12872-024-03924-w
